Concerns regarding overuse and misuse of prescription drugs often result in under-treatment of human pain and suffering. The AMA recognises that it is important to achieve a balance between good pain management through adherence to appropriate medication and patient safety. These two webinars will assist practitioners to achieve this balance.
Webinar 1 will provide an overview of the benefits and limitations of urine testing in patients with chronic pain. It is intended to provide physicians with the knowledge that will help them incorporate urine drug testing into their practice as a tool to monitor patient safety and medication adherence.
– To be held on 25 June 2013 at 1pm EDT
Webinar 2 will be an exploration of a multidimensional clinical approach to the treatment of chronic pain, as well as co-occurring mental health and substance disorders, which can be implemented in both primary care and specialty practices. The course will outline evidence-based options for patient engagement in chronic pain treatment and tips on identifying clinical and support resources in community based settings. The appropriate role of opioid analgesics in the context of active pain recovery will also be reviewed.
– To be held on 26 June 2013 at 1 pm EDT
A series of previous seminar are also available, to access these and to register for the forthcoming seminars, go to the AMA website.
These activities are part of a series of AMA webinars on topics related to responsible opioid prescribing. AMA President Jeremy A. Lazarus said: “The AMA is pleased to offer a series of webinars to help physicians combat prescription drug abuse while promoting responsible pain management.”
Leave a Reply